JCR Pharmaceuticals Co., Ltd.

TSE:4552 Voorraadrapport

Marktkapitalisatie: JP¥88.2b

JCR Pharmaceuticals Beheer

Beheer criteriumcontroles 2/4

De CEO JCR Pharmaceuticals is Shin Ashida, benoemd in Jun2005, heeft een ambtstermijn van 19.42 jaar. bezit rechtstreeks 0.009% van de aandelen van het bedrijf, ter waarde ¥ 7.53M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 6.4 jaar en 4.8 jaar.

Belangrijke informatie

Shin Ashida

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO19.4yrs
Eigendom CEO0.009%
Management gemiddelde ambtstermijn6.4yrs
Gemiddelde ambtstermijn bestuur4.8yrs

Recente managementupdates

Recent updates

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Sep 06
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

Sep 04
What JCR Pharmaceuticals Co., Ltd.'s (TSE:4552) 32% Share Price Gain Is Not Telling You

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Aug 23
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Aug 09
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

Aug 03
Earnings Miss: JCR Pharmaceuticals Co., Ltd. Missed EPS By 90% And Analysts Are Revising Their Forecasts

JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

Jul 26
JCR Pharmaceuticals (TSE:4552) Will Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

Jul 12
JCR Pharmaceuticals (TSE:4552) Is Paying Out A Dividend Of ¥10.00

JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

May 22
JCR Pharmaceuticals Co., Ltd. (TSE:4552) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

Mar 18
JCR Pharmaceuticals (TSE:4552) Is Due To Pay A Dividend Of ¥10.00

JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

Feb 29
JCR Pharmaceuticals (TSE:4552) Has Affirmed Its Dividend Of ¥10.00

CEO

Shin Ashida (81 yo)

19.4yrs

Tenure

Mr. Shin Ashida has been the Chairman of JCR Pharmaceuticals Co., Ltd. since July 1995 and its Chief Executive Officer since June 2005. Mr. Ashida has been the President and Chief Operating Officer of JCR...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Shin Ashida
Chairman19.4yrsgeen gegevens0.0085%
¥ 7.5m
Yoshihiro Ota
Director of Accounting Department & Corporate Strategy Department (Finance)no datageen gegevensgeen gegevens
Yutaka Honda
Sr. Exec. Offi. of Admin.8.4yrsgeen gegevensgeen gegevens
Hiroyuki Fukuya
Director of Legal Affairs Department - Administration Divisionno datageen gegevensgeen gegevens
Toru Ashida
Director4.6yrsgeen gegevens0.22%
¥ 189.9m
Ryutaro Makino
Director of Marketing Dept. & Group Manager of Product Planning - Marketing Dept. for Sales Div.4.1yrsgeen gegevensgeen gegevens
Katsuya Nishino
Executive Vice President14.3yrsgeen gegevensgeen gegevens
Hiroshi Yoshimoto
Senior Advisor13.5yrsgeen gegevensgeen gegevens
Takayo Egawa
Senior Executive Officer & Director of International Affairsno datageen gegevensgeen gegevens
Toshihiro Ishikiriyama
Senior Managing Executive Officer & Executive Director of Business Development Divisionless than a yeargeen gegevens0.0066%
¥ 5.8m
Hiroyuki Sonoda
Senior Managing Executive Officer of Research6.4yrsgeen gegevens0.0019%
¥ 1.7m
Junichi Ando
Managing Executive Officer of Production & Executive Director of Production Division3.4yrsgeen gegevensgeen gegevens

6.4yrs

Gemiddelde duur

70yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van 4552 is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.4 jaar).


Bestuursleden

NaamPositieTenureCompensatieEigendom
Shin Ashida
Chairman19.4yrsgeen gegevens0.0085%
¥ 7.5m
Toru Ashida
Directorno datageen gegevens0.22%
¥ 189.9m
Hiroyuki Sonoda
Senior Managing Executive Officer of Research4.8yrsgeen gegevens0.0019%
¥ 1.7m
Yoshio Hiyama
Director3.4yrsgeen gegevens0.0021%
¥ 1.9m
Andrea Spezzi
Director & Managing Executive Officer of Development Divisionless than a yeargeen gegevensgeen gegevens
Marc Dunoyer
Independent Outside Director1.4yrsgeen gegevensgeen gegevens
Kazuhiko Yamada
Outside Audit & Supervisory Board Member18.4yrsgeen gegevens0.010%
¥ 9.2m
Philippe Fauchet
Independent Outside Director2.4yrsgeen gegevensgeen gegevens
Toshihide Yoda
Independent Outside Director6.4yrsgeen gegevensgeen gegevens
Yutaka Atomi
Independent Outside Director2.4yrsgeen gegevensgeen gegevens
Takashi Suetsuna
Independent Outside Director7.4yrsgeen gegevensgeen gegevens
Yuko Hayashi
Independent Outside Director6.4yrsgeen gegevensgeen gegevens

4.8yrs

Gemiddelde duur

65.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 4552 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.8 jaar).